Omidubicel
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Omidubicel, covering 2025-07-02 to 2026-06-22. Get the full timeline:
Most recent: Clinical Trial Results: Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies [Phase 3]